Compare Fox Corp Class A (FOXA) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fox Corp Class A vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Fox Corp Class A trades at $62.43 (market cap $25.36B), while Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B). The key difference: Fox Corp Class A is far larger — about 2× Halozyme Therapeutics Inc. Common Stock's market cap, and Fox Corp Class A pays a 0.91% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fox Corp Class A for 34 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| FOXA | HALO | |
|---|---|---|
Market Cap | $25.36B | $12.58B |
Volume | 2,566,954 | 2,179,278 |
Sector | Media | Health |
52-Week High | $76.11 | $115.22 |
52-Week Low | $48.79 | $61.63 |
Typical Hold Time | 34 Days | 1 Days |
Enterprise Value | $28.72B | $14.49B |
Dividend Yield | 0.91% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FOXA trades at $62.41, down 0.46% on the day, with a bullish technical signal from moving averages and strong fundamental performance including a 16.3% revenue growth to $16.30B in 2025 and three consecutive quarterly earnings beats. The pending $22B Roku acquisition, currently under DOJ review, represents a major strategic development. Analyst consensus is bullish with a $72.00 price target and no sell ratings among 48 analysts.
The outlook is positive given strong earnings momentum, reasonable valuation (P/E 16.55), and potential upside from the Roku deal. Key risks include regulatory hurdles for the acquisition and a projected decline in 2026 net income. The stock offers a compelling risk-reward profile for investors seeking exposure to media consolidation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Fox Corp Class A
Fox operates in cable networks and television. Its cable segment includes Fox News, Fox Business, and sports channels, while its TV segment covers the Fox network, 29 local stations (18 Fox-affiliated), and the ad-supported streaming service Tubi. After selling most of its entertainment assets to Disney in 2019, Fox now focuses on live news and sports, primarily within pay-TV. The Murdoch family controls the company.
Read more on FOXA →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
